Interim Analysis of Spectranetics’ DCB Released
Interim one-year data from 220 patients in the ILLUMENATE global study assessing Spectranetics’ Stellarex paclitaxel-coated balloon in the superficial...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?